Interestingly, high NCAPH levels were associated with poor clinical outcome of HER2+ luminal tumours (ER positive), confirming that NCAPH did not influence the outcome of HER2‐enriched tumours defined by IHC either (Figure 3A,B). This evidence concerns the gene NCAPH and neoplasm.